KeyBank National Association
ACOR

KeyBank National Association’s Acorda Therapeutics ACOR Stock Holding History

KeyBank National Association’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-117
Closed -$574K – 1255
2014
Q4 		$574K Sell
117
-34
-23% -$146K ﹤0.01% 808
2014
Q3 		$614K Hold
151
– – ﹤0.01% 797
2014
Q2 		$612K Buy
151
+3
+2% +$12.2K ﹤0.01% 835
2014
Q1 		$672K Sell
148
-2
-1% -$8.09K 0.01% 790
2013
Q4 		$524K Hold
150
– – ﹤0.01% 890
2013
Q3 		$615K Buy
150
+2
+1% +$8.62K ﹤0.01% 800
2013
Q2 		$588K Buy
+148
New +$609K ﹤0.01% 935

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

KeyBank National Association's ACOR Position: Q1 2015 in Review

KeyBank National Association sold out of Acorda Therapeutics (ACOR) in Q1 2015, closing a stake of 117 shares — an estimated $574K sold.

KeyBank National Association first reported a position in ACOR in Q2 2013 and held it in 7 quarters. The position peaked at $672K in Q1 2014. 190 funds tracked by Wall St. Rank hold ACOR as of Q1 2015.

  • KeyBank National Association reported no remaining Acorda Therapeutics position as of Q1 2015 after selling out during the quarter.
  • KeyBank National Association sold 117 Acorda Therapeutics shares in Q1 2015, an estimated $574K.
  • KeyBank National Association first reported a position in Acorda Therapeutics in Q2 2013 and held it in 7 quarters.
  • KeyBank National Association's Acorda Therapeutics position peaked at $672K in Q1 2014.
  • 190 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2015.

Based on KeyBank National Association's 13F filing for Q1 2015, filed 7 May 2015.